Phase 1 multicenter trial of CUDC-907 in children and young adults with relapsed or refractory solid tumors, CNS tumors, and lymphoma

MLA

Pei-Chi Kao, et al. “Phase 1 Multicenter Trial of CUDC-907 in Children and Young Adults with Relapsed or Refractory Solid Tumors, CNS Tumors, and Lymphoma.” Journal of Clinical Oncology, vol. 35, May 2017, p. TPS10576. EBSCOhost, https://doi.org/10.1200/jco.2017.35.15_suppl.tps10576.

APA

Pei-Chi Kao, Suzanne Ezrre, Suzanne Shusterman, Wendy B. London, Clay Gustafson, David S. Shulman, Susan N. Chi, Jane E. O’Brien, Gina Hanna, Jodi A. Muscal, Elizabeth Fox, Kieuhoa T. Vo, Cecilia Carlowicz, Jeffrey G. Supko, Andrew E. Place, & Steven G. DuBois. (2017). Phase 1 multicenter trial of CUDC-907 in children and young adults with relapsed or refractory solid tumors, CNS tumors, and lymphoma. Journal of Clinical Oncology, 35, TPS10576. https://doi.org/10.1200/jco.2017.35.15_suppl.tps10576

Chicago

Pei-Chi Kao, Suzanne Ezrre, Suzanne Shusterman, Wendy B. London, Clay Gustafson, David S. Shulman, Susan N. Chi, et al. 2017. “Phase 1 Multicenter Trial of CUDC-907 in Children and Young Adults with Relapsed or Refractory Solid Tumors, CNS Tumors, and Lymphoma.” Journal of Clinical Oncology 35 (May): TPS10576. doi:10.1200/jco.2017.35.15_suppl.tps10576.